Newsroom

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has revised the outlook to negative from stable for the Long-Term Issuer Credit Rating (Long-Term ICR) and affirmed the Financial Strength Rating (FSR) of B++ (Good) and the Long-Term ICR of “bbb+” (Good) of The Baltimore Life Insurance Company (BLIC) (Owings Mills, MD). The outlook of the FSR is stable.The Credit Ratings (ratings) reflect BLIC’s balance sheet strength, which AM Best assesses as strong, as well as its adequate operating performance, limite...

カリフォルニア州サンカルロス--(BUSINESS WIRE)--（ビジネスワイヤ） -- グローバルなオンコロジー企業であるBeOne Medicines Ltd.（NASDAQ：ONC、HKEX：06160、SSE：688235）は、2026年第3四半期の業績ならびに事業の最新情報を発表しました。 BeOneの共同創業者兼会長兼最高経営責任者（CEO）であるジョン・V・オイラーは次のように述べています。 「第3四半期の力強い業績および通期業績予想の上方修正は、血液がん領域における継続的かつ急速なグローバル成長とリーダーシップを反映したものです。これは、患者に強力かつ持続的な奏効をもたらす当社の基幹製品であるBTK阻害剤「BRUKINSA」を中核とし、さらに次世代BCL2阻害剤「BEQALZI」が加わったことなどが下支えとなっています。当社は、血液がんおよび固形がんにまたがる、腫瘍学分野で最も充実したパイプラインから、今後数ヶ月間にわたり複数の好材料が生まれることを期待しています。これは、研究開発、製造、および商業化における当社の差別化された能力によって加速されるものです。」 (単...

LONDON--(BUSINESS WIRE)--  Re: First Abu Dhabi Bank P.J.S.C.   USD 39,000,000.00   MATURING: 15-May-2029   ISIN: XS2821706988     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 17-Aug-2026 TO 16-Nov-2026 HAS BEEN FIXED AT 4.80 PCT   DAY BASIS: ACTUAL/360   INTEREST PAYABLE VALUE 16-Nov-2026 WILL AMOUNT TO: USD 2,427.71 PER USD 200,000.00 DENOMINATION  ...

DALLAS & LYON, France--(BUSINESS WIRE)--Regulatory News: SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris, Code ISIN : FR0014005I80 / Mnémonique : ALSMA, éligible PEA-PME), un acteur franco-américain spécialisé dans la chirurgie rachidienne complexe proposant une solution intégrée pré, intra et postopératoire basée sur un logiciel de planification 3D, des implants adaptatifs et des services associés, annonce aujourd’hui la reconduction du mandat du Dr. T...

DALLAS & LYON, France--(BUSINESS WIRE)--Regulatory News: SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris, ISIN code: FR0014005I80 / Ticker: ALSMA, PEA-PME eligible), a French-American company specialized in complex spine surgery and offering an integrated pre-, intra- and postoperative solution based on 3D planning software, adaptive implants and related services, today announces the renewal of the term of office of Dr Tenner Guillaume, Orthopaedic Surg...

LONDON--(BUSINESS WIRE)--  Re: PARAGON MORTGAGES (NO. 13) PLC   USD  311,000,000.00   MATURING: 15-Nov-2038   ISIN: US69913BAB27     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 17-Aug-2026 TO 16-Nov-2026 HAS BEEN FIXED AT 4.29 PCT   DAY BASIS: ACTUAL/360   INTEREST PAYABLE VALUE 16-Nov-2026 WILL AMOUNT TO: USD      94.82 PER USD  8,744.63 DENOMINATION  ...

LONDON--(BUSINESS WIRE)--  Re: Inter-American Development Bank   USD 1,500,000,000.00   MATURING: 15-Feb-2029   ISIN: US4581X0EC87     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 17-Aug-2026 TO 16-Nov-2026 HAS BEEN FIXED AT 4.10 PCT   DAY BASIS: ACTUAL/360   INTEREST PAYABLE VALUE 16-Nov-2026 WILL AMOUNT TO: USD      10.37 PER USD  1,000.00 DENOMINATION  ...

LONDON--(BUSINESS WIRE)--  Re: Banque Saudi Fransi   USD 20,000,000.00   MATURING: 16-May-2029   ISIN: XS2822519067     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 17-Aug-2026 TO 16-Nov-2026 HAS BEEN FIXED AT 4.96 PCT   DAY BASIS: ACTUAL/360   INTEREST PAYABLE VALUE 16-Nov-2026 WILL AMOUNT TO: USD 250,859.7 PER USD 20,000,000.00 DENOMINATION  ...

LONDON--(BUSINESS WIRE)--  Re: SNB FUNDING LIMITED   USD 10,000,000.00   MATURING: 14-Feb-2030   ISIN: XS2587263679     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 14-Aug-2026 TO 16-Nov-2026 HAS BEEN FIXED AT 5.30 PCT   DAY BASIS: ACTUAL/360   INTEREST PAYABLE VALUE 16-Nov-2026 WILL AMOUNT TO: USD 13.83 PER USD 1,000.00 DENOMINATION  ...

SAN CARLOS, California--(BUSINESS WIRE)--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), empresa mundial dedicada a la oncología, anunció hoy sus resultados financieros y las novedades corporativas del tercer trimestre de 2026. John V. Oyler, cofundador, presidente y director ejecutivo de BeOne, declaró: “Nuestros sólidos resultados del tercer trimestre y las previsiones al alza para todo el año reflejan un crecimiento global rápido y continuo, así como nuestro liderazgo en hemato...